| Financial Year |
March 31 2023 |
| Monetary Funds |
172,881,751.43 |
| Held-for-trading Financial Assets |
14,785,614.31 |
| Notes Receivable |
1,911,130.00 |
| Accounts Receivable |
232,726,101.07 |
| Advances to Suppliers |
215,328,461.33 |
| Other Receivables |
20,334,757.99 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
209,596,671.65 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
25,676,422.58 |
| Total Current Assets |
910,870,992.07 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
20,074,541.52 |
| Fixed Assetes |
112,126,680.28 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
18,538,869.49 |
| R&D expenses |
-- |
| Goodwill |
107,667,369.43 |
| Long-Term Deferred and Prepaid Expenses |
1,619,029.73 |
| Deferred Income Tax Assets |
11,535,257.12 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
286,598,044.21 |
| Total Assets |
1,197,469,036.28 |
| Short-Term Loans |
102,249,727.61 |
| Trading Financial liabilities |
-- |
| Notes Payable |
7,728,237.00 |
| Accounts Payable |
170,042,422.03 |
| Accounts Received In Advance |
60,000.00 |
| Employee Compensation Payable |
3,120,797.96 |
| Taxes Payable |
5,900,438.48 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
175,653,057.69 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,538,350.90 |
| Other Current Liabilities |
5,979,054.97 |
| Sub-Total of Current Liabilities |
521,055,924.72 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
5,103,369.48 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
16,527,969.73 |
| Total Liabilities |
537,583,894.45 |
| Paid-In Capital(Or Share Stock) |
367,753,770.00 |
| Capital Surplus |
568,760,683.63 |
| Surplus Reserve |
23,611,501.67 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-350,620,683.16 |
| Minority Stockholder's Interest |
50,379,869.69 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
609,505,272.14 |
| Owner's Equity（Stockholder's Equity） |
659,885,141.83 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,197,469,036.28 |
